To study the biological significance and potential clinical role of different levels of TROP2 and EpCAM, more than 2,700 tumor samples were analyzed for TROP2 and EpCAM expression by multiplex fluorescence immunohistochemistry in combination with a deep-learning based algorithm for automated cell detection in a tissue microarray (TMA) format. Here, TACSTD2 is linked to neoplasm.